| IPM/CS | Imipenem/Cilastatin |
|---|---|
| I/C | Imipenem/cilastatin |
| IPM/CS | Imipenem/cilastatin sodium |
| IMI | Imipenem |
| IPM | Imipenem |
| imipenem | <chemical> 6-(1-hydroxyethyl)-3-((2-((iminomethyl)amino)ethyl)thio)-7- oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid. Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with cilastatin, a renal dipeptidase inhibitor. Pharmacological action: thienamycins. Chemical name: 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-3-((2-((iminomethyl)amino)ethyl)thio)-7-oxo-, (5R-(5alpha,6alpha(R*)))- (12 Dec 1998) |
|---|---|
| cilastatin | <chemical> A renal dehydropeptidase-I and leukotriene d4 dipeptidase inhibitor. Since the antibiotic, imipenem, is hydrolyzed by dehydropeptidase-I, which resides in the brush border of the renal tubule, cilastatin is administered with imipenem to increase its effectiveness. The drug also inhibits the metabolism of leukotriene d4 to leukeotriene e4. Pharmacological action: protease inhibitors. Chemical name: 2-Heptenoic acid, 7-((2-amino-2-carboxyethyl)thio)-2-(((2,2-dimethylcyclopropyl)carbonyl)amino)-, (R-(R*,S*-(Z)))- (12 Dec 1998) |
| cilastatin sodium | C16H25N2NaO5S;an inhibitor of the renal dipeptidase, dehydropeptidase 1, used, in conjunction with antibiotics subject to metabolism in the kidneys, to increase therapeutic response to the antibiotic. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|